TYP
Click for more information
5.26% 2.0¢ tryptamine therapeutics limited

patent approved, page-40

  1. Pisces
    16,819 Posts.
    lightbulb Created with Sketch. 356
    clock Created with Sketch.
    12/10/21
    23:22
    Post #: 56751671
    I think everyone invested here knows the potential and the pitfalls. Without anyone else pointing it out.

    The next few months are critical. We've brought on some high level execs.. We're moving towards more patents. Interest in exosomes is accelerating.

    I'm hoping if not expecting news on the deal front this quarter.
    EX1 Price at posting: 57.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WAF Drilling at Kiaka Gold Project yields 7.6 g/t intercept for West African
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
MKG Mako reports shallow high grade gold in scout drilling at Tchaga North
right-arrow Created with Sketch.
STX Award of 85 MW capacity pushes Strike's Erregulla power station project closer to FID
right-arrow Created with Sketch.
NEWS Unchanged wage growth in June quarter, but public sector leaps ahead
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.0¢ 		Change
0.001(5.26%) 		Mkt cap ! $21.78M
Open High Low Value Volume
1.9¢ 2.0¢ 1.9¢ $15.61K 781.1K

Buyers (Bids)

No. Vol. Price($)
6 337830 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 275000 2
View Market Depth
Last trade - 13.07pm 16/08/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.